adlitterio66339

About adlitterio66339

This author has not yet filled in any details.
So far adlitterio66339 has created 511 blog entries.

13 10, 2022

Clotilde Sparano et al., Classic and follicular variant of papillary thyroid microcarcinoma: two different phenotypes beyond tumour size

adlitterio663392022-10-20T11:38:05+02:00

10 10, 2022

Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – September2022

adlitterio663392022-10-10T13:45:31+02:00

6 10, 2022

Diatech Pharmacogenetics will participate at the DGHO Annual Conference in Vienna.
Diatech Pharmacogenetics will participate at the DGHO Annual Conference in Vienna.

Events, Nachrichten

Diatech Pharmacogenetics will participate at the DGHO Annual Conference in Vienna.

adlitterio663392022-10-06T11:37:56+02:00

30 09, 2022

Mariam M Al-Omari et al., Review of current in vitro COVID-19 diagnostics methods

adlitterio663392022-10-20T11:40:40+02:00

28 09, 2022

Silvia Chiesa et al., Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma

adlitterio663392022-10-13T15:41:55+02:00

15 09, 2022

Eleonora Nardi et al., A study on the placenta in stillbirth: an evaluation of molecular alterations through next generation sequencing

adlitterio663392022-10-13T15:47:35+02:00

8 09, 2022

Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – August 2022

adlitterio663392022-10-10T12:35:57+02:00

1 09, 2022

Alessandro Dal Maso et al., EGFR T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experience

adlitterio663392022-10-20T11:47:26+02:00

30 08, 2022

Valentina Grespi et al., Human neural stem cells drug product: Microsatellite instability analysis

adlitterio663392022-10-20T11:50:15+02:00

4 08, 2022

Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – July 2022

adlitterio663392022-08-04T09:43:40+02:00

Vorheriges 789 Nächstes